Resultados de la búsqueda 171-180 of 15259 for immunothérapie Bylaska

  1. Hematología - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other places in the ...

  2. Salud del adulto - Mayo Clinic

    De Mayo Clinic a tu buzón. Inscríbete gratis y mantente al día en cuanto a avances en las investigaciones, consejos sobre salud, temas médicos de actualidad ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...

  6. Transplant Center de Mayo Clinic - Ensayos clínicos

    Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas. Rochester, Minn. To investigate the efficacy of autologous Epstein-barr virus (EBV)- ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

  8. Medicina pulmonar - Ensayos clínicos - Mayo Clinic

    REVOLUTION will be a multicenter registry enrolling approximately 2,500 patients. Additional patients limited to those with EGFR mutations may be enrolled ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...